OPIANT PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Santa Monica, CA
SEC filing record 1 source field available
Fiscal year end
31 December
OPIANT PHARMACEUTICALS, INC. has filed 578 SEC EDGAR filings since 11 Jan 2007

SEC filing history

Showing 176-200 of 545 matching filings.

Per page
25
Current page
8
4

FORM 4

Filing date
27 Jan 2021
Reporting date
26 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Jan 2021
Reporting date
26 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Jan 2021
Reporting date
26 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Jan 2021
Reporting date
26 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Jan 2021
Reporting date
26 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-252012

EFFECT filing

Filing date
25 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38193

8-K

Filing date
21 Jan 2021
Reporting date
14 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
21 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
15 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-252012

S-3

Filing date
11 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38193

8-K

Filing date
14 Dec 2020
Reporting date
11 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38193

8-K

Filing date
10 Dec 2020
Reporting date
10 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38193

8-K

Filing date
18 Nov 2020
Reporting date
18 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38193

8-K

Filing date
12 Nov 2020
Reporting date
12 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38193

8-K

Filing date
29 Oct 2020
Reporting date
26 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Sep 2020
Reporting date
03 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38193

8-K

Filing date
28 Jul 2020
Reporting date
28 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
13 Jul 2020
Reporting date
10 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38193

8-K

Filing date
16 Jun 2020
Reporting date
16 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Jun 2020
Reporting date
15 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Jun 2020
Reporting date
15 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Jun 2020
Reporting date
15 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .